MedPath

Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38

Phase 2
Completed
Conditions
Induction of Labor
Interventions
Drug: Propess insertion group
Registration Number
NCT01916291
Lead Sponsor
Seoul National University Hospital
Brief Summary

Dinoprostone(propess) is commonly used for induction of labor in the pregnant women who has intact membrane after 38weeks of gestational age. The investigators study safety and efficacy of dinoprostone in the pregnant women with premature rupture of membrane or GA\<38weeks

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
189
Inclusion Criteria
  • Pregnant women who admitted for induction of labor
  • Bishop score <= 6
Read More
Exclusion Criteria
  • Contraindication to induction of labor
  • Active labor
  • Vaginal bleeding, unknown origin
  • Hypersensitive to Prostaglandin E
  • History of asthma, glaucoma
  • Infection (birth canal)
  • Placental abruption
  • Multiparity(>5)
  • Pelvic inflammatory disease
  • Heart, lung, kidney disease
  • Multiple pregnancy
  • Major anomaly
  • Fetal distress before induction of labor
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Propess insertionPropess insertion group-
Primary Outcome Measures
NameTimeMethod
Induction success rate after propess insertionDay 1 after propess insertion
Secondary Outcome Measures
NameTimeMethod
Concentration of prostaglandinEat delivery

Trial Locations

Locations (2)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul Metropolitan Goverment Seoul National University Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath